ESR1 Mutations in Cell-Free DNA of Breast Cancer Predictive "Tip of the Iceberg"

被引:4
|
作者
Fuqua, Suzanne A. W.
Rechoum, Yassine
Gu, Guowei
机构
[1] Baylor Coll Med, Dept Med, Dan L Duncan Canc Ctr, Lester & Sue Smith Breast Ctr, One Baylor Plaza, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Mol & Cellular Biol, One Baylor Plaza, Houston, TX 77030 USA
关键词
GROWTH;
D O I
10.1001/jamaoncol.2016.1268
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1315 / 1316
页数:3
相关论文
共 50 条
  • [1] Clinical significance of monitoring ESR1 mutations in circulating cell-free DNA in estrogen receptor positive breast cancer patients
    Takeshita, Takashi
    Yamamoto, Yutaka
    Yamamoto-Ibusuki, Mutsuko
    Inao, Toko
    Sueta, Aiko
    Fujiwara, Saori
    Omoto, Yoko
    Iwase, Hirotaka
    ONCOTARGET, 2016, 7 (22) : 32504 - 32518
  • [2] Detection of ESR1 mutations in circulating cell-free DNA from patients with metastatic breast cancer treated with palbociclib and letrozole
    Gyanchandani, Rekha
    Kota, Karthik J.
    Jonnalagadda, Amruth R.
    Minteer, Tanya
    Knapick, Beth A.
    Oesterreich, Steffi
    Brufsky, Adam M.
    Lee, Adrian V.
    Puhalla, Shannon L.
    ONCOTARGET, 2017, 8 (40) : 66901 - 66911
  • [3] ESR1 mutations in breast cancer
    Clatot, Florian
    Augusto, Laetitia
    Di Fiore, Frederic
    AGING-US, 2017, 9 (01): : 17 - 18
  • [4] ESR1 mutations in breast cancer
    Dustin, Derek
    Gu, Guowei
    Fuqua, Suzanne A. W.
    CANCER, 2019, 125 (21) : 3714 - 3728
  • [5] ESR1 Methylation Measured in Cell-Free DNA to Evaluate Endocrine Resistance in Metastatic Breast Cancer Patients
    Bos, Manouk K.
    Deger, Teoman
    Sleijfer, Stefan
    Martens, John W. M.
    Wilting, Saskia M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (10)
  • [6] High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy
    Lupini, Laura
    Moretti, Anna
    Bassi, Cristian
    Schirone, Alessio
    Pedriali, Massimo
    Querzoli, Patrizia
    Roncarati, Roberta
    Frassoldati, Antonio
    Negrini, Massimo
    SCIENTIFIC REPORTS, 2018, 8
  • [7] Highly sensitive detection of ESR1 mutations in cell-free DNA from patients with metastatic breast cancer using molecular barcode sequencing
    Nanae Masunaga
    Naofumi Kagara
    Daisuke Motooka
    Shota Nakamura
    Tomohiro Miyake
    Tomonori Tanei
    Yasuto Naoi
    Masafumi Shimoda
    Kenzo Shimazu
    Seung Jin Kim
    Shinzaburo Noguchi
    Breast Cancer Research and Treatment, 2018, 167 : 49 - 58
  • [8] Highly sensitive detection of ESR1 mutations in cell-free DNA from patients with metastatic breast cancer using molecular barcode sequencing
    Masunaga, Nanae
    Kagara, Naofumi
    Motooka, Daisuke
    Nakamura, Shota
    Miyake, Tomohiro
    Tanei, Tomonori
    Naoi, Yasuto
    Shimoda, Masafumi
    Shimazu, Kenzo
    Kim, Seung Jin
    Noguchi, Shinzaburo
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 167 (01) : 49 - 58
  • [9] Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer Patients
    Wang, Peilu
    Bahreini, Amir
    Gyanchandani, Rekha
    Lucas, Peter C.
    Hartmaier, Ryan J.
    Watters, Rebecca J.
    Jonnalagadda, Amruth R.
    Bittar, Humberto E. Trejo
    Berg, Aaron
    Hamilton, Ronald L.
    Kurland, Brenda F.
    Weiss, Kurt R.
    Mathew, Aju
    Leone, Jose Pablo
    Davidson, Nancy E.
    Nikiforova, Marina N.
    Brufsky, Adam M.
    Ambros, Tadeu F.
    Stern, Andrew M.
    Puhalla, Shannon L.
    Lee, Adrian V.
    Oesterreich, Steffi
    CLINICAL CANCER RESEARCH, 2016, 22 (05) : 1130 - 1137
  • [10] Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer A Secondary Analysis of the BOLERO-2 Clinical Trial
    Chandarlapaty, Sarat
    Chen, David
    He, Wei
    Sung, Patricia
    Samoila, Aliaksandra
    You, Daoqi
    Bhatt, Trusha
    Patel, Parul
    Voi, Maurizio
    Gnant, Michael
    Hortobagyi, Gabriel
    Baselga, Jose
    Moynahan, Mary Ellen
    JAMA ONCOLOGY, 2016, 2 (10) : 1310 - 1315